Fueled by Caffeine said:In reply to AngryCorvair (Forum Supporter) :
Ahh E36 M3 you look like me
i always suspected you were a handsome SOB
Fueled by Caffeine said:In reply to AngryCorvair (Forum Supporter) :
Ahh E36 M3 you look like me
i always suspected you were a handsome SOB
3Q22 sales $2.8M, vs $2.35M in 2Q22 and $1.5M in 3Q21. This puts us at $7.25M YTD, on pace for >$10M for CY22 vs $5.6M for CY21.
now lemme get back out on my corner.
In reply to AngryCorvair (Forum Supporter) :
Congrats- really gaining traction. I'd expect you hit the exponent curve q2 next year.
grover said:In reply to AngryCorvair (Forum Supporter) :
Congrats- really gaining traction. I'd expect you hit the exponent curve q2 next year.
I hope one of the points on that curve is "buy a 911 GT3" :-)
Here’s an article describing how our device improves outcome as measured by freedom from arrhythmia at 12 months after ablation. I posted this from my street corner. Because I'm still the ho.
In reply to AngryCorvair (Forum Supporter) :
You hit the point where you have an insurance reimbursement code? ( Category 3 CPT?)
I retired as a Ho, but have to say that the world of medical devices is not boring. Between the initial innovation/engineering challenges, endless rounds of fundraising, the regulatory rabbit-hole, patent law mazes and clinical approvals, there is never a dull moment.
AngryCorvair (Forum Supporter) said:3Q22 sales $2.8M, vs $2.35M in 2Q22 and $1.5M in 3Q21. This puts us at $7.25M YTD, on pace for >$10M for CY22 vs $5.6M for CY21.
now lemme get back out on my corner.
4Q22 sales came in at $3.46M, so we closed CY22 at $10.71M. It's exciting to see the growth, but I'm ready to see it from a beach somewhere. ;-)
You'll need to log in to post. Log in